MRSA--too many hurdles to overcome: a study from Central India.
Mallick
Sanjay Kumar
SK
Department of Microbiology, Jawaharlal Nehru Medical College, Sawangi (M) Wardha-442004 (MS), India.
Basak
Silpi
S
D000081:Acetamides / Q000494:pharmacology* / Q000627:therapeutic use; D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology* / Q000627:therapeutic use; D002440:Cefoxitin; D024901:Drug Resistance, Multiple, Bacterial; D006801:Humans; D015994:Incidence; D007194:India / Q000453:epidemiology; D020128:Inhibitory Concentration 50; D000069349:Linezolid; D055624:Methicillin-Resistant Staphylococcus aureus / Q000302:isolation & purification*; D008826:Microbial Sensitivity Tests; D023303:Oxazolidinones / Q000494:pharmacology* / Q000627:therapeutic use; D015995:Prevalence; D013203:Staphylococcal Infections / Q000188:drug therapy* / Q000453:epidemiology / Q000382:microbiology; D014640:Vancomycin / Q000494:pharmacology* / Q000627:therapeutic use
D000081:Acetamides; D000900:Anti-Bacterial Agents; D023303:Oxazolidinones; D002440:Cefoxitin; D014640:Vancomycin; D000069349:Linezolid